Skip to main content

Intrathecal Drug Administration

Present Use and Future Trends

Clinical Pharmacokinetics volume 22, pages 319–326 (1992)Cite this article

Conclusions

The intrathecal route of administration should no longer be thought of as an exotic way of treating diseases of the nervous system. With current implantable technology, access to the lumbar subarachnoid space is clinically acceptable and carries a low risk of infection. Moreover, the pharmacokinetics of drugs delivered intrathecally can be as predictable as with any other route of administration.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  • Ahuja SA. Baclofen. In Florey (Ed.) Analytical profiles of drug substances, Vol. 14, pp. 527–548, Academic Press, Orlando, 1985

    Google Scholar 

  • Atweh SF, Kuhar MJ. Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Research 124: 53–67, 1977

    Article  PubMed  CAS  Google Scholar 

  • Bernards CM, Hill HF. Morphine and alfentanil permeability through the spinal dura, arachnoid, and pia mater of dogs and monkeys. Anesthesiology 73: 1214–1219, 1990

    Article  PubMed  CAS  Google Scholar 

  • Blasberg RG, Patlak C, Fenstermacher JD. Intrathecal chemotherapy: brain tissue profiles after ventriculo-cisternal perfusion. Journal of Pharmacology and Experimental Therapeutics 195: 73–83, 1975

    PubMed  CAS  Google Scholar 

  • Bleyer WA, Dedrick RL. Clinical pharmacology of intrathecal methotrexate I: pharmacokinetics in nontoxic patients after lumbar injection. Cancer Treatment Reports 61: 703–708, 1977

    PubMed  CAS  Google Scholar 

  • Bowery NG, Hill DR, Hudson AL. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. British Journal of Pharmacology 78: 191–206, 1983

    Article  PubMed  CAS  Google Scholar 

  • Coombs DW. Intraspinal analgesic infusion by implanted pump. Annals of the New York Academy of Sciences 531: 108–122, 1988

    Article  PubMed  CAS  Google Scholar 

  • Coombs DW, Fratkin JD, Meier FA, Nierenberg DW, Saunders RL. Neuropathologic lesions and CSF morphine concentrations during chronic continuous intraspinal morphine infusion: a clinical and post-mortem study. Pain 22: 337–351, 1985

    Article  PubMed  CAS  Google Scholar 

  • Cradock JC, Kleinman LM, Davignon JP. Intrathecal injections: a review of pharmaceutical factors. Bulletin of the Parenteral Drug Association 31: 237–247, 1977

    PubMed  CAS  Google Scholar 

  • Faull RLM, Villiger JW. Opiate receptors in the human spinal cord: a detailed anatomical study comparing the autoradiographic localization of 3H-diprenorphine binding sites with the laminar pattern of substance P, myelin and Nissl staining. Neuroscience 20: 395–407, 1987

    Article  PubMed  CAS  Google Scholar 

  • Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesthesia and Analgesia 64: 715–730, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hattab JR. Review of European clinical trials with baclofen. In Feldman et al. (Eds) Spasticity: disordered motor control, pp. 71–75, Symposia Specialists, Miami, 1980

    Google Scholar 

  • Hill DR, Bowery NG. [3H]Baclofen and [3H]GABA bind to bicuculline-insensitive GABABsites in rat brain. Nature 290: 149–152, 1981

    Article  PubMed  CAS  Google Scholar 

  • Kaufman JJ, Semo NM, Koski WS. Microelectrometric measurement of the pKa’s and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence. Journal of Medical Chemistry 18: 647–655, 1975

    Article  CAS  Google Scholar 

  • Kessler JA, Fenstermacher JD, Owens ES. Spinal subarachnoid perfusion of rhesus monkeys. American Journal of Physiology 230: 614–618, 1976

    PubMed  CAS  Google Scholar 

  • Knutsson E, Lindblom U, Må A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. Journal of the Neurological Sciences 23: 473–484, 1974

    Article  PubMed  CAS  Google Scholar 

  • Kotab HIM, Hand CW, Moore RA, Evans PJD, Wells J, et al. Intrathecal morphine and heroin in humans: six-hour drug levels in spinal fluid and plasma. Anesthesia and Analgesia 65: 718–722, 1986

    Google Scholar 

  • Krames ES, Gershow J, Glassberg A, Kenefick T, Lyons A, et al. Continuous infusion of spinally administered narcotics for the relief of pain due to malignant disorders. Cancer 56: 6696–702, 1985

    Article  Google Scholar 

  • Kroin JS, Penn RD. Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In Lakke et al. (Eds) Parenteral drug therapy in spasticity and Parkinson’s disease, pp. 73–83, Parthenon Publishing, Carnforth, 1991

    Google Scholar 

  • Kroin JS, Penn RD, Beissinger RL, Arzbaecher RC. Reduced spinal reflexes following intrathecal baclofen in the rabbit. Experimental Brain Research 54: 191–194, 1984

    Article  CAS  Google Scholar 

  • Lamotte C, Pert CE, Snyder SH. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Research 112: 407–412, 1976

    Article  PubMed  CAS  Google Scholar 

  • Lazorthes Y, Sallerin-Caute B, Verdie J-C, Bastide R, Carillo J-P. Chronic intrathecal baclofen administration for control of severe spasticity. Journal of Neurosurgery 72: 393–402, 1990

    Article  PubMed  CAS  Google Scholar 

  • Leavens ME, Hill CS, Cech DA, Weyland JB, Weston JS. Intrathecal and intraventricular morphine for pain in cancer patients: initial study. Journal of Neurosurgery 56: 241–245, 1982

    Article  PubMed  CAS  Google Scholar 

  • Moore A, Bullingham R, McQuay H, Allen M, Baldwin D, et al. Spinal fluid kinetics of morphine and heroin. Clinical Pharmacology and Therapeutics 35: 40–45, 1984

    Article  PubMed  CAS  Google Scholar 

  • Moulin DE, Inturrisi CE, Foley KM. Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala5-D-Leu5-enkephalin. Annals of Neurology 20: 218–222, 1986

    Article  PubMed  CAS  Google Scholar 

  • Müller H, Zierski J, Dralle D, Hoffman O, Michaelis G. Intrathecal baclofen in spasticity. In Müller et al. (Eds) Local-spinal therapy of spasticity, pp. 155–214, Springer-Verlag, Berlin, 1988a

    Chapter  Google Scholar 

  • Müller H, Zierski J, Dralle D, Krauss D, Mutschler E. Pharmacokinetics of intrathecal baclofen. In Müller et al. (Eds) Local-spinal therapy of spasticity, pp. 223–226, Springer-Verlag, Berlin, 1988b

    Chapter  Google Scholar 

  • Munsat TL, Taft J, Kasdon D, Jackson IMD. Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis. Annals of the New York Academy of Sciences 531: 187–193, 1988

    Article  PubMed  CAS  Google Scholar 

  • Nordberg G, Hedner T, Meilstrand T, Dahlström B. Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 60: 448–454, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. Journal of Neurology, Neurosurgery and Psychiatry 52: 933–939, 1989

    Article  CAS  Google Scholar 

  • Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clinic Proceedings 56: 516–520, 1981

    PubMed  CAS  Google Scholar 

  • Payne R, Inturrisi CE. CSF distribution of morphine, methadone and sucrose after intrathecal injection. Life Sciences 37: 1137–1144, 1985

    Article  PubMed  CAS  Google Scholar 

  • Penn RD. Drug pumps for treatment of neurological diseases and pain. Neurologic Clinics 3: 439–452, 1985

    PubMed  CAS  Google Scholar 

  • Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078, 1984

    Article  PubMed  CAS  Google Scholar 

  • Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet 2: 125–127, 1985

    Article  PubMed  CAS  Google Scholar 

  • Penn RD, Kroin JS. Long-term intrathecal baclofen for spasticity. Journal of Neurosurgery 66: 181–185, 1987

    Article  PubMed  CAS  Google Scholar 

  • Penn RD, Kroin JS. Intrathecal baclofen in the long-term management of severe spasticity. In Park et al. (Eds) Management of spasticity in cerebral palsy and spinal cord injury, pp. 325–332, Hanley and Belfus, Philadelphia, 1989

    Google Scholar 

  • Penn RD, Kroin JS, Magolan JM. Intrathecal baclofen in the treatment of spinal spasticity. Clinical Neuropharmacology 33 (Suppl. 2): 400–401, 1990

    Google Scholar 

  • Penn RD, Paice JA, Gottshalk W, Ivankovich AD. Cancer pain relief using chronic morphine infusion: early experience with a programmable implanted drug pump. Journal of Neurosurgery 61: 302–306, 1984

    Article  PubMed  CAS  Google Scholar 

  • Penn RD, Savoy S, Corcos D, Latash, Gottlieb G, et al. Intrathecal baclofen for severe spinal spasticity: a double-blind crossover study. New England Journal of Medicine 320: 1517–1521, 1989

    Article  PubMed  CAS  Google Scholar 

  • Price GW, Wilkin GP, Turnbull MJ, Bowery NG. Are baclofen-sensitive GABAB receptors present on primary afferent terminals of the spinal cord? Nature 307: 71–74, 1984

    Article  PubMed  CAS  Google Scholar 

  • Reddy SVR, Maderdrut JL, Yaksh TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. Journal of Pharmacology and Experimental Therapeutics 213: 525–533, 1980

    PubMed  CAS  Google Scholar 

  • Rieselbach RE, DiChiro G, Freireich EJ, Rall DP. Subarachnoid distribution of drugs after lumbar injection. New England Journal of Medicine 267: 1273–1278, 1962

    Article  PubMed  CAS  Google Scholar 

  • Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rall DP. The production of cerebrospinal fluid in man and its modification by acetazolamide. Journal of Neurosurgery 25: 430–436, 1966

    Article  PubMed  CAS  Google Scholar 

  • Schoenen J, Faull RLM. Spinal cord: chemoarchitectural organization. In Paxinos (Ed.) The human nervous system, pp. 55–75, Academic Press, San Diego, 1990

    Google Scholar 

  • Schwab ME, Schnell L. Channeling of developing rat corticospinal tract axons by myelin-associated neurite growth inhibitors. Journal of Neuroscience 11: 709–721, 1991

    PubMed  CAS  Google Scholar 

  • Schwarz M, Klockgether T, Turski L, Sontag K-H. Intrathecal injection of antispastic drugs in rats: muscle relaxant action of midazolam, baclofen, 2-aminophosphonoheptanoic acid (AP7) and tizanidine. In Müller et al. (Eds) Local-spinal therapy of spasticity, pp. 65–79, Springer-Verlag, Berlin, 1988

    Chapter  Google Scholar 

  • Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. New England Journal of Medicine 293: 161–166, 1975

    Article  PubMed  CAS  Google Scholar 

  • Sjöström S, Tamsen A, Persson MP, Hartvig P. Pharmacokinetics of intrathecal morphine in humans. Anesthesiology 67: 889–895, 1987

    Article  PubMed  Google Scholar 

  • Spaulding TC, Venafro JJ, Ma MG, Fielding S. The dissociation of the antinociceptive effect of Clonidine from supraspinal structures. Neuropharmacology 18: 103–105, 1979

    Article  PubMed  CAS  Google Scholar 

  • Timmermans PBMWM, van Zwieten PA. Correlations between central hypotensive and peripheral hypertensive effects of structurally dissimilar alpha-adrenoceptor agonists. Life Sciences 28: 653–660, 1981

    Article  PubMed  CAS  Google Scholar 

  • Tuszynski MH, U HS, Amaral DG, Gage FH. Nerve growth factor infusion in the primate brain reduces lesion-cholinergic neuronal degeneration. Journal of Neuroscience 10: 3604–3614, 1990

    PubMed  CAS  Google Scholar 

  • Unnerstall JR, Kopajtic TA, Kuhar MJ. Distribution of alpha2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of Clonidine and related adrenergic agents. Brain Research Reviews 7: 69–101, 1984

    Article  CAS  Google Scholar 

  • Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proceedings of the National Academy of Sciences of the United States of America 83: 9231–9235, 1986

    Article  PubMed  CAS  Google Scholar 

  • Yaksh TL, Kohl RL, Rudy TA. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. European Journal of Pharmacology 42: 275–284, 1977

    Article  PubMed  CAS  Google Scholar 

  • Yaksh TL, Reddy SVR. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, α-adrenergic agonists and baclofen. Anesthesiology 54: 451–467, 1981

    Article  PubMed  CAS  Google Scholar 

  • Yaksh TL, Rudy TA. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. Journal of Pharmacology and Experimental Therapeutics 202: 411–428, 1977

    PubMed  CAS  Google Scholar 

  • Yen J, Reiss FL, Kimelberg HK, Bourke RS. Direct administration of methotrexate into the central nervous system of primates. Journal of Neurosurgery 48: 895–902, 1978

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Rush Medical College, 1653 W. Congress Parkway, Chicago, Illinois, 60612, USA

    Jeffrey S. Kroin

Authors
  1. Jeffrey S. Kroin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kroin, J.S. Intrathecal Drug Administration. Clin. Pharmacokinet. 22, 319–326 (1992). https://doi.org/10.2165/00003088-199222050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199222050-00001

Keywords

  • Morphine
  • Baclofen
  • GABAB Receptor
  • Intrathecal Morphine
  • Intrathecal Baclofen